[Dr Jean Languillon (1912-2003), a major unrecognized leprologist].

Le Dr Jean Languillon (1912-2003), un léprologue majeur trop méconnu.
Institut Marchoux Jean Languillon Leprology Order of Malta Sub-Saharan Africa

Journal

Medecine tropicale et sante internationale
ISSN: 2778-2034
Titre abrégé: Med Trop Sante Int
Pays: France
ID NLM: 9918227363206676

Informations de publication

Date de publication:
30 06 2023
Historique:
received: 22 03 2023
accepted: 31 03 2023
medline: 2 8 2023
pubmed: 1 8 2023
entrez: 1 8 2023
Statut: epublish

Résumé

Languillon's contribution to the control of leprosy cannot be reduced to the manual of leprology which remains the reference for anyone working on this disease in sub-Saharan Africa. This would mean forgetting his works that established the immunological origin of leprosy and its cutaneous, adverse and neurological complications.Another major aspect, the importance of his contribution to the treatment of the disease, in particular through the development of polychimiotherapy (PCT), which has made Institut Marchoux in Bamako one of the five WHO's collaborating centers in the field of clinical research in leprosy.Languillon was also involved in a holistic approach of the disease by creating the first leprosy surgery unit and implementing physiotherapy, orthopedic care with appropriate equipment, and social rehabilitation… without forgetting preventive aspects of complications through the necessary regular administration of treatments, and control of patients spread over wide territories, by creating a corps of leprosy nurse monitors and leprosy specialists. These will provide essential support to the doctor most often in charge of a huge sector where the need of assistance was obvious.Languillon ended his African career by creating the ILAD, Institute of Applied Leprology in Dakar, which offers the full range of care, as he always advocated.Finally, he did not resist the call of Order of Malta which offered him to share his expertise in the different countries where the Order was involved.

Identifiants

pubmed: 37525670
doi: 10.48327/mtsi.v3i2.2023.379
pmc: PMC10387308
pii:
doi:

Types de publication

English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 SFMTSI.

Auteurs

Jean Paul Louis (JP)

Diplômé de médecine tropicale, titulaire du CES de santé publique et de la spécialité de recherches du Service de santé des armées en lutte contre les grandes endémies.

Francis Louis (F)

Spécialiste des hôpitaux des armées en biologie et diplômé de santé publique. Président-fondateur de l'Association des anciens et amis du Pharo, « Ceux du Pharo ».

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH